Get started
Author

Sieglinde Haye

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria‐mediated apoptosis
2003 · Bodo Schniewind, Matthias Christgen, et al. · International Journal of Cancer · 120
Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer
2003 · Susanne Müerköster, Alexander Arlt, et al. · International Journal of Cancer · 94
PDF
Treating diabetes with islet transplantation: Lessons from the past decade in Lille
2014 · M.-C. Vantyghem, F. Defrance, et al. · Diabetes & Metabolism · 47
Immunoglobulin G, A and M and Antibody Response in Sow-Reared and Artificially-Reared Pigs
1979 · S. N. Haye, E. T. Kornegay · Journal of Animal Science · 24
Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model
2006 · Juergen Tepel, Marie-Luise Kruse, et al. · Pancreatology · 19
Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer
2002 · Roland Kurdow, Arnd S. Boehle, et al. · The Annals of Thoracic Surgery · 12
Antibody Response and Serum Protein and Immunoglobulin Concentrations in Pigs from Sows Fed Different Protein Sequences during Gestation and Lactation
1981 · S. N. Haye, E. T. Kornegay, et al. · Journal of Animal Science · 10
Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
2004 · Roland Kurdow, Bodo Schniewind, et al. · PubMed · 8
49 Gemcitabine mediates cell death in human pancreatic cancer by recruitment of CD95 and the mitochondrial apoptosis pathway
2003 · B. Schniewind, M. Christgen, et al. · European Journal of Cancer Supplements
Works count: 10
Citation count: 334
H-index: 8
I10-index: 7
Year
Topic
Type